SOL is closing in on US$145, pushing Chinaamc Solana Etf (03460.HK) toward a fourth straight session of gains.
SOL has been consolidating between US$120 and US$145 since 14 November 2025. A New Epoch Research tally shows the US$145 ceiling has already rejected four rally attempts in the past three months. As of 10:29 a.m. Chinaamc Solana Etf (03460.HK) is up more than 4.3% intraday, gunning for a fourth consecutive daily gain. (Data: Wind, 14 Jan 2026.)
On the news front, whale-tracking platform Onchain Lens posted on 9 January that a crypto “megawhale” deposited US$8.09 mn and placed SOL bid orders stacked at US$133.88-135. Even though the token had been range-bound, the oversized ticket underlines continued high-conviction buying.
Separately, on 6 January Wall Street heavyweight Morgan Stanley filed with the U.S. SEC to launch exchange-traded funds covering both Bitcoin and Solana.
HKEX data show that Chinaamc Solana Etf (03460.HK)—issued by China Asset Management (Hong Kong)—is the city’s first spot-SOL ETF and, after BTC and ETH products, the third crypto-spot ETF approved by the SFC. Listed on 8 July 2025, it is USD-denominated, trades in 10-share board lots and allows same-day (T+0) round trips. The fund holds 100% physical SOL in cold-storage, multi-sig wallets provided by licensed custodian OSL, with addresses published daily.
Historically, SOL plunged as much as 96% between November 2021 and January 2023 and, in 2022, registered a single-day crash of 42.28%. (Data: Wind)
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Offshore Trust Insight | HIGHTIDE THERAPEUTICS (02511.HK) Up 0.16% Intraday; Two Trustee Chains Hold 143.61 Million Shares via BVI Platforms
- HK Stock Connect Insight | IMPRO PRECISION (01286.HK) Falls About 28% Since Stock Connect Inclusion; Full-Year Sales Growth Guidance Raised to 20%-25% on August 11
- AI Chip Concept Stocks Insight | ASMPT (00522.HK) down 3.62%, advanced packaging to top 50% of OSAT market in 2026
- Humanoid Robot Concept Stocks Insight | XIAOMI-W (01810.HK) up 1.50%, China's humanoid robot output tops 40,000 units in H1
- LYGEND RESOURCE (02245.HK): Guarantee for Wholly-Owned Subsidiary's RMB500m Credit Facility